论文信息 - Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial (LBA 5) - 字舞流文

Efficacy and safety of niraparib as maintenance treatment in patients with newly diagnosed advanced ovarian cancer using an individualized starting dose (PRIME Study): A randomized, double-blind, placebo-controlled, phase 3 trial (LBA 5)

G. Lou | B. Kong | Ning Li | Yi Huang | Lingying Wu | P. Qu | Hongqin Zhao | R. Yin | Hongying Yang | Xiaohua Wu | D. Zou | Jihong Liu | Gui-Chen Li | Li Wang | Jianqing Zhu | H. Zheng | W. Lu | Jing Wang | A. Lin | Ke Wang | Jianmei Hou | X. Zhen | W. Hang | L. Pan | Chunyan Wang | Hong Zheng